Advertisement

Topics

Immuno-oncology firm Elicio launches, raises $30mm in first round

15:40 EDT 15 Apr 2019 | Elsevier Business Intelligence

Elicio Therapeutics announced its launch and $30mm in Series A funding from undisclosed investors. The company is developing ...

Original Article: Immuno-oncology firm Elicio launches, raises $30mm in first round

NEXT ARTICLE

More From BioPortfolio on "Immuno-oncology firm Elicio launches, raises $30mm in first round"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pancreatic Cancer
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secrete hormones; Insulinoma, Gastrinoma, Somatostatinoma, VI...